Jefferies maintained a buy rating on Sun Pharma with a target price of Rs 1310. The Q2 miss was largely on higher operating expenses.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
Jefferies maintained a buy rating on Sun Pharma with a target price of Rs 1310. The Q2 miss was largely on higher operating expenses.
| Subscribe To Our Free Newsletter |
